| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | -3.85% | Goldman Sachs | $1.3 → $1 | Maintains | Sell |
| 08/01/2023 | 284.62% | JMP Securities | → $4 | Reiterates | Market Outperform → Market Outperform |
| 08/01/2023 | 861.54% | HC Wainwright & Co. | → $10 | Reiterates | Buy → Buy |
| 05/11/2023 | 284.62% | JMP Securities | → $4 | Reiterates | Market Outperform → Market Outperform |
| 05/09/2023 | 861.54% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 05/05/2023 | 284.62% | JMP Securities | → $4 | Maintains | Market Outperform |
| 04/27/2023 | 284.62% | JMP Securities | → $4 | Reiterates | → Market Outperform |
| 03/08/2023 | 284.62% | JMP Securities | → $4 | Reiterates | → Market Outperform |
| 03/03/2023 | 284.62% | JMP Securities | → $4 | Reiterates | → Market Outperform |
| 03/03/2023 | 861.54% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 12/21/2021 | 380.77% | JMP Securities | $8 → $5 | Maintains | Market Outperform |
| 12/21/2021 | 861.54% | HC Wainwright & Co. | $14 → $10 | Maintains | Buy |
| 08/05/2020 | 92.31% | Morgan Stanley | $4 → $2 | Maintains | Equal-Weight |
| 08/05/2020 | 1246.15% | HC Wainwright & Co. | $25 → $14 | Maintains | Buy |
| 04/06/2020 | 861.54% | Citigroup | $14 → $10 | Maintains | Buy |
| 03/18/2020 | 284.62% | Morgan Stanley | $11 → $4 | Maintains | Equal-Weight |
| 03/17/2020 | 476.92% | Stifel | $18 → $6 | Downgrades | Buy → Hold |
| 01/09/2020 | 1630.77% | Stifel | $10 → $18 | Upgrades | Hold → Buy |
| 12/16/2019 | 1246.15% | Citigroup | → $14 | Initiates Coverage On | → Buy |
| 06/17/2019 | 1246.15% | Goldman Sachs | → $14 | Initiates Coverage On | → Buy |
| 12/20/2018 | 861.54% | Morgan Stanley | $26 → $10 | Maintains | Equal-Weight |
| 12/20/2018 | 669.23% | Barclays | $30 → $8 | Downgrades | Overweight → Equal-Weight |
| 12/20/2018 | — | Jefferies | Downgrades | Buy → Hold | |
| 12/20/2018 | 1823.08% | JMP Securities | $30 → $20 | Reiterates | → Market Outperform |
| 11/02/2018 | 2784.62% | B of A Securities | $33 → $30 | Maintains | Buy |
What is the target price for DBV Technologies (DBVT)?
The latest price target for DBV Technologies (NASDAQ: DBVT) was reported by Goldman Sachs on November 2, 2023. The analyst firm set a price target for $1.00 expecting DBVT to fall to within 12 months (a possible -3.85% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DBV Technologies (DBVT)?
The latest analyst rating for DBV Technologies (NASDAQ: DBVT) was provided by Goldman Sachs, and DBV Technologies maintained their sell rating.
When is the next analyst rating going to be posted or updated for DBV Technologies (DBVT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DBV Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DBV Technologies was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating DBV Technologies (DBVT) correct?
While ratings are subjective and will change, the latest DBV Technologies (DBVT) rating was a maintained with a price target of $1.30 to $1.00. The current price DBV Technologies (DBVT) is trading at is $1.04, which is out of the analyst's predicted range.